"Zhongheng" and "Buy" work together to create a Chinese medicine carrier
Release time: 2010-12-03 & nbsp & nbsp & nbsp Source:
November 30，Steps Pharmaceutical、Wuzhou Pharmaceuticals two leading Chinese medicine companies held a press conference in Beijing for announcement，New mode of implementation of production and sales cooperation，Comparative sales system，Sharing Sales Network，Flows to achieve a win -win production and sales，Standing foothold in the new round of "reshuffle"。
Guangxi Zhongheng Group Wuzhou Pharmaceutical Co., Ltd. and Buchang Pharmaceutical Group "Alliance"，The sales team and dealer network are handed over to the management and operation of Shandong Buchang Pharmaceutical My stake betting appSales Stake Sports BettingCompany, a subsidiary of Buchang Pharmaceutical Group，Both parties will share product sales networks in the next 5 years。
A few days ago，Department of Industry and Information Technology、The Ministry of Health and the State Food and Drug Administration issued the "Guiding Opinions on Accelerating the Structure of the Medical Industry"，Put forward to promote the optimization and upgrade of the structure of the pharmaceutical industry，Realizing the transformation of my country's pharmaceutical industry from great to strong，Stir "One Pond of Spring Water"。Experts point out，The introduction of "Opinions"，It will promote my country's pharmaceutical industry to enter the structural adjustment period，Among them, the main manifestation is that mergers and reorganization and industry reshuffle will accelerate，Optimized structure is expected to enter a healthier and sustainable growth period。Expert prediction，In this critical period of the survival of the enterprise，Large scale、Pharmaceuticals and sales companies with a high level of intensive level will gain an advantageous development position。
Industry analysts think，This move aims to be strongly united、Complement of advantages，Promote the simultaneous growth of their respective production and sales，Enhance the development of enterprise development，At the same time，Enterprises have the courage to break the stake betting appstake betting apptraditional production and sales bundle mode，"Test Water" production and sales cooperation new model，It also explains that in the face of "structural adjustment" policy，The sense of urgency of pharmaceutical enterprises is further enhanced。
It is reported，Wuzhou Pharmaceutical and Buchang Pharmaceuticals are large and tax households in the province and region、Key leading enterprise。Zhongheng Group Wuzhou Pharmaceutical is integrated development、Production、Modernized comprehensive high -tech pharmaceutical enterprise sold in one in one，At present, 13 production lines are fully passed through GMP certification，Have strong product research and development capabilities and production capacity，It is recognized as "National High -tech Enterprise"。At the same time, it has a national -level Wuzhou Pharmaceutical Modern Dalibous Chinese Medicine R & D Center and the autonomous region -level Guangxi Pharmaceutical Purification Engineering Technology Research Center。With 309 drug registration certificates，11 major dosage type、21 national exclusive production varieties，92 "Chinese Pharmacopoeia" collection varieties，11 countries in Chinese medicine protection varieties，5 countries in invention patented products，With rich drug resources and good brand resources。Where，injection of injection and thrombosis of Wuzhou Pharmaceuticals developed and produced by the National Invention Patent Product，My stake betting appStake Sports Bettingand enter the national basic drug directory，It has become the first choice for the treatment of cardiovascular and cerebrovascular diseases in China。
Shandong Buchang Pharmaceutical Sales Company, which belongs to the Building Pharmaceutical Group, is one of the largest pharmaceutical sales companies in my country，Except Xi'an, headquarters of the group company，Also in Beijing、Shanghai、There are branches in Guangdong，Branches are all over the major provinces in China，Sales network crossing covers 15,000 hospitals across the country and 130,000 retail pharmacies，With a complete pharmaceutical sales system and a sound marketing mechanism，Market operation advantage is very prominent。
At the same time，The goals and measures of the development of the Chinese medicine industry proposed by the "Opinions" of the three departments，It has also become a powerful "pushing hand" for the development of Chinese medicine companies。The Opinions are clearly proposed，We must adhere to inheritance and innovation，Drawing on the development experience of international natural drugs，Accelerate the secondary research and development of Chinese medicines，Priority to develop medicines in the field of treatment with the advantages of traditional Chinese medicine。
The person in charge of Wuzhou Pharmaceutical said，After cooperation between the two parties，Enterprise Stake Sports Bettingstake sports betting apprelying on modern dosage type Chinese medicine research and development center and drug purification engineering technology research center，Concentrated energy to do a good job of modern Chinese medicine development、Production and quality control，and this is undoubtedly a strong promotion for strengthening the Chinese medicine industry。
Guangxi Zhongheng Group Wuzhou Pharmaceutical Co., Ltd. and Buchang Pharmaceutical Group "Alliance"，The sales team and dealer network are handed over to the management and operation of Shandong Buchang Pharmaceutical My stake betting appSales Stake Sports BettingCompany, a subsidiary of Buchang Pharmaceutical Group，Both parties will share product sales networks in the next 5 years。
A few days ago，Department of Industry and Information Technology、The Ministry of Health and the State Food and Drug Administration issued the "Guiding Opinions on Accelerating the Structure of the Medical Industry"，Put forward to promote the optimization and upgrade of the structure of the pharmaceutical industry，Realizing the transformation of my country's pharmaceutical industry from great to strong，Stir "One Pond of Spring Water"。Experts point out，The introduction of "Opinions"，It will promote my country's pharmaceutical industry to enter the structural adjustment period，Among them, the main manifestation is that mergers and reorganization and industry reshuffle will accelerate，Optimized structure is expected to enter a healthier and sustainable growth period。Expert prediction，In this critical period of the survival of the enterprise，Large scale、Pharmaceuticals and sales companies with a high level of intensive level will gain an advantageous development position。
Industry analysts think，This move aims to be strongly united、Complement of advantages，Promote the simultaneous growth of their respective production and sales，Enhance the development of enterprise development，At the same time，Enterprises have the courage to break the stake betting appstake betting apptraditional production and sales bundle mode，"Test Water" production and sales cooperation new model，It also explains that in the face of "structural adjustment" policy，The sense of urgency of pharmaceutical enterprises is further enhanced。
It is reported，Wuzhou Pharmaceutical and Buchang Pharmaceuticals are large and tax households in the province and region、Key leading enterprise。Zhongheng Group Wuzhou Pharmaceutical is integrated development、Production、Modernized comprehensive high -tech pharmaceutical enterprise sold in one in one，At present, 13 production lines are fully passed through GMP certification，Have strong product research and development capabilities and production capacity，It is recognized as "National High -tech Enterprise"。At the same time, it has a national -level Wuzhou Pharmaceutical Modern Dalibous Chinese Medicine R & D Center and the autonomous region -level Guangxi Pharmaceutical Purification Engineering Technology Research Center。With 309 drug registration certificates，11 major dosage type、21 national exclusive production varieties，92 "Chinese Pharmacopoeia" collection varieties，11 countries in Chinese medicine protection varieties，5 countries in invention patented products，With rich drug resources and good brand resources。Where，injection of injection and thrombosis of Wuzhou Pharmaceuticals developed and produced by the National Invention Patent Product，My stake betting appStake Sports Bettingand enter the national basic drug directory，It has become the first choice for the treatment of cardiovascular and cerebrovascular diseases in China。
Shandong Buchang Pharmaceutical Sales Company, which belongs to the Building Pharmaceutical Group, is one of the largest pharmaceutical sales companies in my country，Except Xi'an, headquarters of the group company，Also in Beijing、Shanghai、There are branches in Guangdong，Branches are all over the major provinces in China，Sales network crossing covers 15,000 hospitals across the country and 130,000 retail pharmacies，With a complete pharmaceutical sales system and a sound marketing mechanism，Market operation advantage is very prominent。
At the same time，The goals and measures of the development of the Chinese medicine industry proposed by the "Opinions" of the three departments，It has also become a powerful "pushing hand" for the development of Chinese medicine companies。The Opinions are clearly proposed，We must adhere to inheritance and innovation，Drawing on the development experience of international natural drugs，Accelerate the secondary research and development of Chinese medicines，Priority to develop medicines in the field of treatment with the advantages of traditional Chinese medicine。
The person in charge of Wuzhou Pharmaceutical said，After cooperation between the two parties，Enterprise Stake Sports Bettingstake sports betting apprelying on modern dosage type Chinese medicine research and development center and drug purification engineering technology research center，Concentrated energy to do a good job of modern Chinese medicine development、Production and quality control，and this is undoubtedly a strong promotion for strengthening the Chinese medicine industry。
